OpenURL Connection Search

Select item for more details and to access through your institution.

New insights in Type I and II CD20 antibody mechanismsof- action with a panel of novel CD20 antibodies.
Published in:
British Journal of Haematology, 2018, v. 180, n. 6, p. 808, doi. 10.1111/bjh.15132
By:
- Meyer, Saskia;
- Evers, Mitchell;
- Jansen, Johannes H. M.;
- Buijs, Jos;
- Broek, Blanca;
- Reitsma, Stephanie E.;
- Moerer, Petra;
- Amini, Mojtaba;
- Kretschmer, Anna;
- Broeke, Toine ten;
- den Hartog, Marcel T.;
- Rijke, Mark;
- Klein, Christian;
- Valerius, Thomas;
- Boross, Peter;
- Leusen, Jeanette H. W.
Publication type:
Article
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.
Published in:
Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46321-9
By:
- Foss, Stian;
- Sakya, Siri A.;
- Aguinagalde, Leire;
- Lustig, Marta;
- Shaughnessy, Jutamas;
- Cruz, Ana Rita;
- Scheepmaker, Lisette;
- Mathiesen, Line;
- Ruso-Julve, Fulgencio;
- Anthi, Aina Karen;
- Gjølberg, Torleif Tollefsrud;
- Mester, Simone;
- Bern, Malin;
- Evers, Mitchell;
- Bratlie, Diane B.;
- Michaelsen, Terje E.;
- Schlothauer, Tilman;
- Sok, Devin;
- Bhattacharya, Jayanta;
- Leusen, Jeanette
Publication type:
Article
Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 3063, doi. 10.1007/s00262-023-03478-4
By:
- Stip, Marjolein C.;
- Jansen, J. H. Marco;
- Nederend, Maaike;
- Tsioumpekou, Maria;
- Evers, Mitchell;
- Olofsen, Patricia A.;
- Meyer-Wentrup, Friederike;
- Leusen, Jeanette H. W.
Publication type:
Article
Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
Published in:
Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00704
By:
- Brandsma, Arianne M.;
- Bondza, Sina;
- Evers, Mitchell;
- Koutstaal, Rosanne;
- Nederend, Maaike;
- Jansen, J. H. Marco;
- Rösner, Thies;
- Valerius, Thomas;
- Leusen, Jeanette H. W.;
- ten Broeke, Toine
Publication type:
Article
Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents.
Published in:
Antibodies (2073-4468), 2020, v. 9, n. 4, p. 70, doi. 10.3390/antib9040070
By:
- van Tetering, Geert;
- Evers, Mitchell;
- Chan, Chilam;
- Stip, Marjolein;
- Leusen, Jeanette
Publication type:
Article

Found: 5

New insights in Type I and II CD20 antibody mechanismsof- action with a panel of novel CD20 antibodies.

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.

Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains.

Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.

Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents.